Avoiding Consequences for Noncompliance with New PTO Rules Requiring Coordination of Submissions to Government Agencies

29 Oct , 2024

To register for the upcoming live webinar, please Click Here

This course is designed to alert patent practitioners with the PTO rules on the “Duty of Disclosure and Reasonable Inquiry” as clarified by the PTO’s notice in Vol. 87 (No. 145) of the Federal Register (July 29, 2022). This course will also address the dire consequences for violating these rules. Most importantly, the course will outline procedures for ensuring that patent practitioners and their clients follow these rules, and thus prevent any PTO investigations and findings of inequitable conduct in subsequent litigation.

Accordingly, the rules, as clarified, state that patent practitioners have an affirmative duty to conduct a reasonable investigation (“duty of inquiry”) to ensure that all statements to the PTO and other government agencies are consistent (“duty of disclosure”). These requirements are particularly pertinent when prosecuting patents that cover a drug, biologic or medical device that require FDA approval. The duty of inquiry requires that statements made to the PTO must be evaluated to ensure they are consistent with statements to the FDA or any other government agency, such as the EPA or Department of Agriculture. Any failure can have adverse consequences to patent practitioners and their clients. After reviewing the rules and consequences for their possible violation, the course will enumerate various steps that should be taken by both patent and regulatory attorneys to ensure that the rules are not violated.

 

To register for the upcoming live webinar, please Click Here

More Webcasts

Modern Cross-Examina...

Attendees will learn how to effectively cross-examine witnesses at trial.  The conventional wis...

Federal Contractor B...

As the largest purchaser of goods and services in the world, the United States Government requires f...

Grand Jury Proceedin...

The bar that grand jury targets face in challenging a grand jury subpoena or seeking access to a gra...

Billing Brilliance: ...

Unrecorded time, vague entries, and end-of-month write-offs cost firms significant revenue. This pra...

NDAs: Beware the Rou...

Confidentiality Agreements (also called NDAs) are too often treated as routine.  So routine, th...

IP Law Part 1: Found...

Every IP question a client brings starts with two decisions: which regime (patent, trademark, copyri...

How To Win Bid Prote...

During this course you will take a deep dive into federal bid protest litigation at the U.S. Court o...

Conducting an Intern...

Conducting an internal investigation that is incisive, effective and legally compliant is tough enou...

POLAROID at 65 - Lik...

This program examines the legal standards and factors courts throughout the United States apply when...

There’s a Reporter...

You’ve arranged to speak with a reporter. Do you know how to deliver insights that are memorab...